State MO
Clinical Trials in Missouri
Missouri is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Missouri and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
Right now ClinicalMetric tracks 275 actively recruiting studies with Missouri sites out of 275 registered in total. The busiest research areas in Missouri are Obesity, Heart Failure, Multiple Myeloma. Leading sponsors running trials in the state include Washington University School of Medicine, National Cancer Institute (NCI), AstraZeneca. By stage, Missouri trials break down as Phase 1 (52), Phase 2 (71), Phase 3 (78), Phase 4 (10).
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Missouri
Frequently Asked Questions — Clinical Trials in Missouri
How many clinical trials are currently recruiting in Missouri?
ClinicalMetric currently tracks 275 actively recruiting clinical trials with at least one location in Missouri. The total number of registered studies—including active but not currently enrolling trials—is 275. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Missouri?
Missouri hosts clinical trials across a broad range of medical conditions, including Obesity, Heart Failure, Multiple Myeloma, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Missouri serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Missouri?
To join a clinical trial in Missouri, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Missouri maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Missouri
NCT05489705 N/A
Recruiting
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treat...
Condition
Obstructive Hypertrophic Cardiomyopathy
Enrollment
1,700 pts
Location
United States, Austria, Czechia
Sponsor
Bristol-Myers Squibb
NCT05566769 N/A
Recruiting
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMO...
Condition
Neuromyelitis Optica
Enrollment
103 pts
Location
United States, France, Germany
Sponsor
Ad scientiam
NCT06742996 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib ...
Condition
Mantle Cell Lymphoma
Enrollment
300 pts
Location
United States, Argentina, Australia
Sponsor
BeOne Medicines
NCT07361562 Phase 1
Recruiting
A Study of a Selective ERBB2 Inhibitor (CGT4255), in Patients With Advanced Soli...
Condition
Advanced Solid Tumor, Adult
Enrollment
100 pts
Location
United States
Sponsor
Cogent Biosciences, Inc.
NCT04699591 N/A
Recruiting
Compassionate Use of Domperidone for Refractory Gastroparesis
Condition
GERD
Enrollment
20 pts
Location
United States
Sponsor
Jose Cocjin
NCT04398628 N/A
Recruiting
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Condition
Hematologic Disorder
Enrollment
3,000 pts
Location
United States
Sponsor
American Thrombosis and Hemost
NCT07204275 Phase 2, Phase 3
Recruiting
Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants...
Condition
Primary Membranous Nephropathy
Enrollment
176 pts
Location
United States, Australia, Brazil
Sponsor
Vertex Pharmaceuticals Incorpo
NCT05281731 N/A
Recruiting
Sonobiopsy for Noninvasive and Sensitive Detection of Glioblastoma
Condition
Glioblastoma
Enrollment
40 pts
Location
United States
Sponsor
Washington University School o
NCT07085767 Phase 3
Recruiting
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/...
Condition
Breast Cancer
Enrollment
1,000 pts
Location
United States, Australia, Austria
Sponsor
Olema Pharmaceuticals, Inc.
NCT07554521 Phase 2
Recruiting
A Study to Evaluate Efficacy and Safety of Tislelizumab Plus Chemotherapy for Lo...
Condition
Advanced Unresectable Gastric Adenocarcinoma
Enrollment
30 pts
Location
United States
Sponsor
BeOne Medicines
NCT07092514 Phase 2
Recruiting
Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioa...
Condition
Thyroid Cancer
Enrollment
34 pts
Location
United States
Sponsor
Washington University School o
NCT06129838 N/A
Recruiting
Investigation of Inflammation in Alzheimer's Disease and Related Dementias (ADRD...
Condition
Alzheimer Disease
Enrollment
80 pts
Location
United States
Sponsor
Washington University School o
NCT07547540 Phase 1
Recruiting
A Study of LY3971297 in Participants With Heart Failure
Condition
Heart Failure
Enrollment
90 pts
Location
United States, Japan, Moldova
Sponsor
Eli Lilly and Company
NCT07166120 N/A
Recruiting
Precision Treatment to Promote Smoking Cessation and Survival in Oncology Patien...
Condition
Smoking Cessation
Enrollment
132 pts
Location
United States
Sponsor
Washington University School o
NCT07815678 Phase 1, Phase 2
Recruiting
First-in-human Study of the Safety, Tolerability, Pharmacokinetics, and Food Eff...
Condition
Obesity
Enrollment
164 pts
Location
United States
Sponsor
Aconcagua Bio, Inc. a wholly o
NCT07358078 N/A
Recruiting
DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients ...
Condition
Transthyretin Amyloidosis With Cardiomyopathy
Enrollment
2,000 pts
Location
United States, Germany, Japan
Sponsor
Alnylam Pharmaceuticals
NCT07895420 Phase 4
Recruiting
Comparing Intravitreal Injection Pain Scores Using Iheezo (Chloroprocaine Hcl Op...
Condition
No Condition
Enrollment
80 pts
Location
United States
Sponsor
Retina Research Institute, LLC
NCT06998524 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Typ...
Condition
Von Willebrand Disease, Type 3
Enrollment
75 pts
Location
United States, Belgium, Canada
Sponsor
Hoffmann-La Roche
NCT07759154 Phase 3
Recruiting
A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hy...
Condition
Attention-deficit/Hyperactivity Disorder
Enrollment
80 pts
Location
United States
Sponsor
Otsuka Pharmaceutical Developm
NCT05656261 N/A
Recruiting
APOL1 Genetic Testing in African Americans
Condition
Genetic Predisposition
Enrollment
600 pts
Location
United States
Sponsor
St. Louis University
NCT07842172 Phase 3
Recruiting
Somatostatin Analogues vs. Observation After Peptide Receptor Radionuclide Thera...
Condition
Neuroendocrine Neoplasm
Enrollment
240 pts
Location
United States
Sponsor
Washington University School o
NCT07369154 Phase 3
Recruiting
52-week Open Label Safety-Tolerability Study
Condition
Schizophrenia
Enrollment
900 pts
Location
United States
Sponsor
LB Pharmaceuticals Inc.
NCT06767514 Phase 3
Recruiting
Clinical Study of Ivonescimab for First-line Treatment of Metastatic NSCLC Patie...
Condition
Non-Small Cell Lung Cancer
Enrollment
780 pts
Location
United States, Belgium, Canada
Sponsor
Summit Therapeutics
NCT07397338 Phase 1, Phase 2
Recruiting
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Sol...
Condition
Advanced Solid Tumors
Enrollment
370 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
NCT07116967 Phase 3
Recruiting
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants Wit...
Condition
Plaque Psoriasis
Enrollment
3,040 pts
Location
United States, Argentina, Australia
Sponsor
Bristol-Myers Squibb
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology